Telemedicine support for hepatitis C treatment
Part of Infections clinical trials.
This trial uses telemedicine to help people with an active hepatitis C infection get care and treatment. It aims to make it easier for patients to access specialists without traveling.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have an active hepatitis C infection (confirmed by a test).
- You must be willing to use telemedicine (video or phone) for medical visits.
- You must be able to provide informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to make hepatitis C testing and treatment easier to access in Canada. It involves different people, like those at risk, healthcare workers, and policy makers, to find better ways to offer care.
This study tests a new way to help primary care doctors remember to screen their adult patients for HIV, hepatitis B, and hepatitis C. It aims to make sure more people get tested for these infections during regular checkups.
This study tests whether using telemedicine (video or phone check-ins) can help manage care for people with advanced liver cirrhosis. It may make it easier to stay connected with your care team without needing to travel to every appointment.
This study focuses on screening, treating, and eliminating hepatitis C. It is for people who may be at risk or newly diagnosed, and aims to connect them with care that could help clear the virus.
This study tests a telehealth program that provides support for people who inject drugs, focusing on preventing HIV and improving care for hepatitis C. It is designed specifically for people living in rural areas of the Deep South and offers a phone or video-based program that is trauma-informed and builds resilience.
This study tests a simple treatment for Hepatitis C in people experiencing unsheltered homelessness. It aims to help those who are receiving street medicine care and have not been treated before.
Hear when a new HCV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.